130 related articles for article (PubMed ID: 29926700)
1. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Mauvieux L; Miguet L; Fornecker L
N Engl J Med; 2018 Jun; 378(25):2442-3. PubMed ID: 29926700
[No Abstract] [Full Text] [Related]
2. How Do We Use Multicolor Flow Cytometry to Detect Minimal Residual Disease in Acute Myeloid Leukemia?
Xu J; Jorgensen JL; Wang SA
Clin Lab Med; 2017 Dec; 37(4):787-802. PubMed ID: 29128069
[TBL] [Abstract][Full Text] [Related]
3. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Ulrich BC
N Engl J Med; 2018 Jun; 378(25):2442. PubMed ID: 29926698
[No Abstract] [Full Text] [Related]
4. Molecular Minimal Residual Disease in Acute Myeloid Leukemia.
Löwenberg B; Valk PJM
N Engl J Med; 2018 Jun; 378(25):2443. PubMed ID: 29924951
[No Abstract] [Full Text] [Related]
5. Monitoring of minimal residual disease in acute myeloid leukemia: methods and best applications.
Jorgensen JL; Chen SS
Clin Lymphoma Myeloma Leuk; 2011 Jun; 11 Suppl 1():S49-53. PubMed ID: 22035748
[TBL] [Abstract][Full Text] [Related]
6. Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.
Chen X; Cherian S
Clin Lab Med; 2017 Dec; 37(4):753-769. PubMed ID: 29128067
[TBL] [Abstract][Full Text] [Related]
7. Minimal Residual Disease in Acute Myeloid Leukemia.
Sung PJ; Luger SM
Curr Treat Options Oncol; 2017 Jan; 18(1):1. PubMed ID: 28110381
[TBL] [Abstract][Full Text] [Related]
8. Patient-tailored analysis of minimal residual disease in acute myeloid leukemia using next-generation sequencing.
Malmberg EB; StÄhlman S; Rehammar A; Samuelsson T; Alm SJ; Kristiansson E; Abrahamsson J; Garelius H; Pettersson L; Ehinger M; Palmqvist L; Fogelstrand L
Eur J Haematol; 2017 Jan; 98(1):26-37. PubMed ID: 27197529
[TBL] [Abstract][Full Text] [Related]
9. [Advances in minimal residual disease detection with flow cytometry in childhood acute myeloid leukemia].
Feng JH; Xu XJ; Tang YM
Zhonghua Er Ke Za Zhi; 2013 Mar; 51(3):231-4. PubMed ID: 23751588
[No Abstract] [Full Text] [Related]
10. A refined approach to detect and measure minimal residual disease in childhood acute myeloid leukemia by flow cytometry.
Capolunghi F; Capponi C; De Stefani B; Luciani M; Locatelli F; Muraca M; Carsetti R
Am J Hematol; 2014 Mar; 89(3):343-4. PubMed ID: 24265183
[No Abstract] [Full Text] [Related]
11. Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings.
Voskova D; Schoch C; Schnittger S; Hiddemann W; Haferlach T; Kern W
Cytometry B Clin Cytom; 2004 Nov; 62(1):25-38. PubMed ID: 15468339
[TBL] [Abstract][Full Text] [Related]
12. [Detection of minimal residual disease in leukemia using flow cytometry].
Muroi K
Rinsho Ketsueki; 2008 Jun; 49(6):397-407. PubMed ID: 18646607
[No Abstract] [Full Text] [Related]
13. [Measurement of minimal residual disease and its implication].
Tsurusawa M; Hori T
Nihon Rinsho; 2012 Apr; 70 Suppl 2():731-6. PubMed ID: 23134035
[No Abstract] [Full Text] [Related]
14. The role of multiparameter flow cytometry for detection of minimal residual disease in acute myeloid leukemia.
Al-Mawali A; Gillis D; Lewis I
Am J Clin Pathol; 2009 Jan; 131(1):16-26. PubMed ID: 19095561
[TBL] [Abstract][Full Text] [Related]
15. Minimal residual disease detection by flow cytometry.
Ludwig WD
Lab Hematol; 2004; 10(3):169. PubMed ID: 15529435
[No Abstract] [Full Text] [Related]
16. Flow cytometry reveals the nuances of clonal haematopoiesis.
Hasserjian RP
Br J Haematol; 2021 Mar; 192(6):949-950. PubMed ID: 33605429
[No Abstract] [Full Text] [Related]
17. [Quantification of minimal residual disease by multiparameter flow cytometry in acute myeloid leukemia. From diagnosis to prognosis].
Kern W; Haferlach T
Med Klin (Munich); 2005 Jan; 100(1):54-9. PubMed ID: 15654545
[TBL] [Abstract][Full Text] [Related]
18. Readying the minimal residual disease concept in acute myeloid leukaemia for prime time - the American way.
Hokland P; Cotter F
Br J Haematol; 2013 Aug; 162(4):429-30. PubMed ID: 23772825
[No Abstract] [Full Text] [Related]
19. The Prognostic Significance of Measurable ("Minimal") Residual Disease in Acute Myeloid Leukemia.
Buccisano F; Hourigan CS; Walter RB
Curr Hematol Malig Rep; 2017 Dec; 12(6):547-556. PubMed ID: 29027628
[TBL] [Abstract][Full Text] [Related]
20. Effect of processing time on analysis of rare event in minimal residual disease study.
Rai S; Bhardwaj U; Singh S; Misra A
Indian J Pathol Microbiol; 2017; 60(3):449-451. PubMed ID: 28937402
[No Abstract] [Full Text] [Related]
[Next] [New Search]